Page last updated: 2024-11-13

clorobiocin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

clorobiocin: chlorine-containing antibiotic related to novobiocin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54706138
CHEMBL ID303984
SCHEMBL ID315426
SCHEMBL ID6937051
MeSH IDM0048666

Synonyms (26)

Synonym
18631 rp
rp 18,631
nsc 227186
1h-pyrrole-2-carboxylic acid, 5-methyl-, 3'-ester with n-(8-chloro-7-((6-deoxy-5-c-methyl-4-o-methyl-alpha-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)benzamide
antibiotic rp 18,631
rp 18631
chlorobiocin
clorobiocin
39868-96-7
5-methyl-1h-pyrrole-2-carboxylic acid (3r,4s,5r,6s)-6-[8-chloro-4-hydroxy-3-({1-[4-hydroxy-3-(3-methyl-but-2-enyl)-phenyl]-methanoyl}-amino)-2-oxo-2h-1-benzopyran-7-yloxy]-5-hydroxy-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester
[(3r,4s,5r,6s)-6-[8-chloro-4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-2-oxo-chromen-7-yl]oxy-5-hydroxy-3-methoxy-2,2-dimethyl-tetrahydropyran-4-yl] 5-methyl-1h-pyrrole-2-carboxylate
DB03966
1KZN
CHEMBL303984 ,
bdbm50330317
5-methyl-1h-pyrrole-2-carboxylic acid (3r,4s,5r,6s)-6-{8-chloro-4-hydroxy-3-[4-hydroxy-3-(4-methyl-pent-3-enyl)-benzoylamino]-2-oxo-2h-chromen-7-yloxy}-5-hydroxy-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester
5-methyl-1h-pyrrole-2-carboxylic acid (3r,4s,5r,6s)-6-{8-chloro-4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-2-oxo-2h-chromen-7-yloxy}-5-hydroxy-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester
SCHEMBL315426
SCHEMBL6937051
n-[8-chloro-7-({6-deoxy-5-methyl-4-o-methyl-3-o-[(5-methyl-1h-pyrrol-2-yl)carbonyl]-beta-d-gulopyranosyl}oxy)-4-hydroxy-2-oxo-2h-chromen-3-yl]-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide
[(3r,4s,5r,6s)-6-[8-chloro-4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-2-oxochromen-7-yl]oxy-5-hydroxy-3-methoxy-2,2-dimethyloxan-4-yl] 5-methyl-1h-pyrrole-2-carboxylate
DTXSID401028112
HY-123515
CS-0082871
gtpl12127
AKOS040746715

Research Excerpts

Overview

Clorobiocin is an aminocoumarin antibiotic containing a pyrrole-2-carboxyl moiety, attached through an ester bond to a deoxysugar. It is a natural antibiotic isolated from several Streptomyces strains.

ExcerptReferenceRelevance
"Clorobiocin is an aminocoumarin antibiotic containing a pyrrole-2-carboxyl moiety, attached through an ester bond to a deoxysugar. "( Acyl transfer in clorobiocin biosynthesis: involvement of several proteins in the transfer of the pyrrole-2-carboxyl moiety to the deoxysugar.
Freitag, A; Heide, L; Li, SM; Wemakor, E, 2005
)
2.11
"Clorobiocin is an aminocoumarin antibiotic containing a 5-methylpyrrolyl-2-carboxyl moiety, attached by an ester bond to a deoxysugar. "( Biosynthesis of clorobiocin: investigation of the transfer and methylation of the pyrrolyl-2-carboxyl moiety.
Alt, S; Anderle, C; Bringmann, G; Gulder, T; Gust, B; Heide, L; Kammerer, B, 2007
)
2.13
"Clorobiocin is a natural antibiotic isolated from several Streptomyces strains and differs from novobiocin in that the methyl group at the 8 position in the coumarin ring of novobiocin is replaced by a chlorine atom, and the carbamoyl at the 3' position of the noviose sugar is substituted by a 5-methyl-2-pyrrolylcarbonyl group."( The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
Breeze, AL; Ladbury, JE; O'Brien, R; Pauptit, RA; Poyser, JP; Singh, OM; Skarzynski, T; Tsai, FT; Tucker, A; Weston, S; Wigley, DB; Wonacott, AJ, 1997
)
1.22
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA gyrase subunit BStaphylococcus aureusIC50 (µMol)0.00850.00401.50207.7000AID1497253
DNA gyrase subunit BEscherichia coli K-12IC50 (µMol)0.03900.00500.43985.2300AID529382; AID529383
DNA gyrase subunit AStaphylococcus aureusIC50 (µMol)0.00850.00401.98397.7000AID1497253
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Dna Gyrase Subunit BEscherichia coliKd0.00120.00120.00120.0012AID977611
DNA gyrase subunit BEscherichia coli K-12Kd0.00120.00120.01210.0280AID704336
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA gyrase subunit AEscherichia coli K-12Activity1.60000.28001.71603.2000AID529385
Cell division inhibitor SulAEscherichia coli K-12Activity1.00001.00003.65006.3000AID529386
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
DNA topological changeDNA gyrase subunit AEscherichia coli K-12
DNA-templated transcriptionDNA gyrase subunit AEscherichia coli K-12
response to xenobiotic stimulusDNA gyrase subunit AEscherichia coli K-12
DNA-templated DNA replicationDNA gyrase subunit AEscherichia coli K-12
DNA topological changeDNA gyrase subunit AEscherichia coli K-12
response to antibioticDNA gyrase subunit AEscherichia coli K-12
chromosome organizationDNA gyrase subunit AEscherichia coli K-12
negative regulation of DNA-templated DNA replicationDNA gyrase subunit AEscherichia coli K-12
DNA topological changeDNA gyrase subunit BEscherichia coli K-12
DNA-templated transcriptionDNA gyrase subunit BEscherichia coli K-12
response to xenobiotic stimulusDNA gyrase subunit BEscherichia coli K-12
DNA-templated DNA replicationDNA gyrase subunit BEscherichia coli K-12
DNA topological changeDNA gyrase subunit BEscherichia coli K-12
response to antibioticDNA gyrase subunit BEscherichia coli K-12
chromosome organizationDNA gyrase subunit BEscherichia coli K-12
DNA damage responseCell division inhibitor SulAEscherichia coli K-12
SOS responseCell division inhibitor SulAEscherichia coli K-12
negative regulation of protein polymerizationCell division inhibitor SulAEscherichia coli K-12
negative regulation of cytokinesisCell division inhibitor SulAEscherichia coli K-12
negative regulation of cell divisionCell division inhibitor SulAEscherichia coli K-12
negative regulation of FtsZ-dependent cytokinesisCell division inhibitor SulAEscherichia coli K-12
division septum assemblyCell division inhibitor SulAEscherichia coli K-12
SOS responseCell division inhibitor SulAEscherichia coli K-12
negative regulation of cytokinesisCell division inhibitor SulAEscherichia coli K-12
cell divisionCell division inhibitor SulAEscherichia coli K-12
negative regulation of cell divisionCell division inhibitor SulAEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
DNA bindingDNA gyrase subunit AEscherichia coli K-12
DNA topoisomerase activityDNA gyrase subunit AEscherichia coli K-12
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA gyrase subunit AEscherichia coli K-12
protein bindingDNA gyrase subunit AEscherichia coli K-12
ATP bindingDNA gyrase subunit AEscherichia coli K-12
ATP-dependent activity, acting on DNADNA gyrase subunit AEscherichia coli K-12
DNA negative supercoiling activityDNA gyrase subunit AEscherichia coli K-12
identical protein bindingDNA gyrase subunit AEscherichia coli K-12
DNA bindingDNA gyrase subunit BEscherichia coli K-12
DNA topoisomerase activityDNA gyrase subunit BEscherichia coli K-12
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA gyrase subunit BEscherichia coli K-12
protein bindingDNA gyrase subunit BEscherichia coli K-12
ATP bindingDNA gyrase subunit BEscherichia coli K-12
ATP-dependent activity, acting on DNADNA gyrase subunit BEscherichia coli K-12
DNA negative supercoiling activityDNA gyrase subunit BEscherichia coli K-12
metal ion bindingDNA gyrase subunit BEscherichia coli K-12
protein bindingCell division inhibitor SulAEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
chromosomeDNA gyrase subunit AEscherichia coli K-12
cytoplasmDNA gyrase subunit AEscherichia coli K-12
cytosolDNA gyrase subunit AEscherichia coli K-12
membraneDNA gyrase subunit AEscherichia coli K-12
cytoplasmDNA gyrase subunit AEscherichia coli K-12
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA gyrase subunit AEscherichia coli K-12
chromosomeDNA gyrase subunit BEscherichia coli K-12
cytoplasmDNA gyrase subunit BEscherichia coli K-12
cytosolDNA gyrase subunit BEscherichia coli K-12
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA gyrase subunit BEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (54)

Assay IDTitleYearJournalArticle
AID529386Inhibition of Escherichia coli K-12 DNA sulA expressed in Escherichia coli DC2 assessed as compound concentration required for => 4-fold induction of luxCDABE operon by reported gene assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID206134In vitro antibacterial activity against Staphylococcus aureus 011GO76 OfloOxaEry-R strain1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
AID206814In vitro antibacterial activity against Streptococcus pyogenes O2A1UC1 strain1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
AID206219In vitro antibacterial activity against Staphylococcus epidermidis 012GO39 OxaTei-R1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID206813In vitro antibacterial activity against Streptococcus pyogenes O2A1UC11999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID78718IC50 was determined for gyrase B of Staphylococcus aureus against novobiocin (0.5 mg/mL) as reference; IC50nov/IC50comp2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID207647Antibacterial activity against Staphylococcus aureus novobiocin resistant strain 011HT11999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID206168Tested for in vitro antibacterial activity against Staphylococcus aureus 011 GO64 ofloxacin oxacillin erythromycin resistance phenotype; Not determined2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID68566Tested for in vitro antibacterial activity against Enterococcus faecium 02D31P2 vancomycin teicoplanin erythromycin resistance phenotype2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID529394Antibacterial activity against Enterococcus faecium ATCC 19434 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529382Inhibition of Escherichia coli JM109 DNA gyrase subunit B assessed as ATP hydrolysis by ATPase assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529391Antibacterial activity against Streptococcus pneumoniae SL336-T by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529396Antibacterial activity against Escherichia coli UB1005 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID206133In vitro antibacterial activity against Staphylococcus aureus 011GO76 OfloOxaEry-R1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID78711In vitro inhibition of supercoiling activity of Escherichia coli DNA gyrase as the ratio of IC50 of Clorobiocin of the compound1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID205910Tested for in vitro antibacterial activity against Staphylococcus epidermidis 012GO42 oxacillin resistance phenotype; Not determined2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID1497254Inhibition of Staphylococcus aureus DNA gyrase assessed as reduction in relaxation of pBR322 DNA at 1.5 ug by SDS-PAGE analysis relative to control2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
AID529383Inhibition of Escherichia coli JM109 DNA gyrase subunit B assessed as DNA triple helix formation by supercoiling assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID704336Binding affinity to Escherichia coli GyrB2011Journal of medicinal chemistry, Feb-24, Volume: 54, Issue:4
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
AID529512Antibacterial activity against Pseudomonas aeruginosa K799/WT by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529509Antibacterial activity against Escherichia coli DC2 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529387Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID207650Antibacterial activity against ofloxacin, oxacillin and erythromycin resistant Staphylococcus aureus strain 011GO761999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID529389Antibacterial activity against Staphylococcus aureus 80CR5 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529392Antibacterial activity against Streptococcus pneumoniae TUPELO by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID209285Antibacterial activity against Streptococcus pyogenes 02A1UC1 strain1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID229527Ratio of IC50 compared to novobiocin in Escherichia coli DNA gyrase supercoiling assay1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID206139In vitro antibacterial activity against Staphylococcus aureus 011HT3 strain1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
AID1339211Inhibition of Staphylococcus aureus DNA gyrase A expressed in Escherichia coli BL21(DE3) using relaxed pBR322 DNA as substrate incubated for 1 hr by bromophenol blue dye based agarose gel electrophoresis method
AID68224Compound was evaluated for antibacterial activity against vancomycin, teicoplanin and erythromycin resistant Enterococcus faecium 02D31P2 strain; Not determined1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID529390Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID206170Tested for in vitro antibacterial activity against Staphylococcus aureus 011 HT1 novobiocin resistance phenotype2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID206220In vitro antibacterial activity against Staphylococcus epidermidis 012GO39 OxaTei-R strain1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
AID206137In vitro antibacterial activity against Staphylococcus aureus 011HT1 Nov-R strain1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
AID207642Antibacterial activity against Staphylococcus aureus 011HT3 strain1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID206136In vitro antibacterial activity against Staphylococcus aureus 011HT1 Nov-R1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID529385Inhibition of Escherichia coli K-12 DNA gyrase A expressed in Escherichia coli DC2 assessed as compound concentration required for => 4-fold induction of luxCDABE operon by reported gene assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID1497253Inhibition of Staphylococcus aureus DNA gyrase assessed as reduction in relaxation of pBR322 DNA by SDS-PAGE analysis2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
AID205578Antibacterial activity against oxacillin and teicoplanin resistant Staphylococcus epidermidis 012GO39 strain1999Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
AID529511Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529395Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID68238In vitro antibacterial activity against Enterococcus faecium 02D31P2 VanTeiEry-R; Not determined1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID53458In vitro inhibition of supercoiling activity of Escherichia coli DNA gyrase subunit B compared to novabiocin.1999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
AID529393Antibacterial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID206171Tested for in vitro antibacterial activity against Staphylococcus aureus 011 HT3 phenotype2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID209780Tested for in vitro antibacterial activity against Streptococcus pyogenes O2A1UC1 phenotype2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
AID1454751Inhibition of bacterial DNA gyrase subunit B2018Journal of medicinal chemistry, 03-22, Volume: 61, Issue:6
Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry.
AID206138In vitro antibacterial activity against Staphylococcus aureus 011HT31999Bioorganic & medicinal chemistry letters, Oct-04, Volume: 9, Issue:19
Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
AID529388Antibacterial activity against Staphylococcus aureus ATCC 43300 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529513Antibacterial activity against Pseudomonas aeruginosa K799/61 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529510Antibacterial activity against Klebsiella pneumoniae ATCC 27736 by broth microdilution method2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID529384Ratio of IC50 for Escherichia coli JM109 DNA gyrase subunit B by ATPase assay to IC50 for Escherichia coli JM109 DNA gyrase subunit B by supercoiling assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2002Biochemistry, Jun-11, Volume: 41, Issue:23
DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.
AID1811Experimentally measured binding affinity data derived from PDB2002Biochemistry, Jun-11, Volume: 41, Issue:23
DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (70)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (14.29)18.7374
1990's6 (8.57)18.2507
2000's37 (52.86)29.6817
2010's15 (21.43)24.3611
2020's2 (2.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.34 (24.57)
Research Supply Index4.26 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]